Patent directory · USPTO A61K / A61P
Patents matching “Darwin Discovery Limited”
55 pharma patents match "Darwin Discovery Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 55 pharmaceutical patents matching "Darwin Discovery Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7994299
Compositions and methods for increasing bone mineralization
granted -
US 7977312
Compositions and methods for increasing bone mineralization
granted -
US 7758858
Antibodies associated with alterations in bone density
granted -
US 7192583
Methods for modulating bone mineralization
granted -
US 6933306
Hydroxamic and carboxylic acid derivatives
expired -
US 6884618
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
expired -
US 6818622
Selective MMP inhibitors having reduced side-effects
expired -
US 6809100
Hydroxamic acid derivatives
expired -
US 6803453
Antibodies associated with alterations in bone density
expired -
US 6794145
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
expired -
US 6787536
Hydroxamic acid derivatives
expired -
US 6734189
Hydroxamic and carboxylic acid derivatives
expired -
US 6706719
Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
expired -
US 6683160
Antibodies specific for Fkhsf gene products
expired -
US 6683171
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
expired -
US 6667162
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
expired -
US 6514994
Levobupivacaine and its use
expired -
US 6506773
Hydroxamic and carboxylic acid derivatives
expired -
US 6506764
Hydroxamic and carboxylic acid derivatives
expired -
US 6503910
Hydroxamic and carboxylic acid derivatives
expired -
US 6495736
Compositions and methods for increasing bone mineralization
expired -
US 6469020
Hydroxamic and carboxylic acid derivatives
expired -
US 6465468
Hydroxamic and carboxylic acid derivatives
expired -
US 6462042
Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors
expired